Association of gray matter atrophy with age, β-amyloid, and cognition in aging

Cerebral Cortex

Volumn 24, Issue 6, 2014, Pages 1609-1618

  Oh, Hwamee ^a   Madison, Cindee ^a   Villeneuve, Sylvia ^a   Markley, Candace ^a   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Aging; Amyloid; Cognition; Pittsburgh compound B positron emission tomography; Structure

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B; APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ARTICLE; BRAIN; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FRONTAL CORTEX; GRAY MATTER; GRAY MATTER ATROPHY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE TEMPORAL GYRUS; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; TEMPORAL CORTEX; ALZHEIMER DISEASE; AMYLOID PLAQUE; ATROPHY; GENETICS; IMAGE PROCESSING; ORGAN SIZE; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGY; REGRESSION ANALYSIS;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; ATROPHY; BRAIN; COGNITION; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PLAQUE, AMYLOID; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS;

EID: 84900484405     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bht017     Document Type: Article

References (46)

1. Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML. 2009. Apoli-poprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci USA. 106:2018-2022.
2. Alexander GE, DeLong MR, Strick PL. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 9:357-381.
3. Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN. 2006. Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Ann Neurol. 60:145-147.
4. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S et al. 2011. Amyloid-beta associated cortical thinning in clinically normal elderly. Ann Neurol. 69:1032-1042.
5. Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D et al. 2010. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 74:121-127.
6. Braak H, Braak E. 1991. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:213-216.
7. Buckner RL. 2004. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron. 44:195-208.
8. Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ et al. 2010. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 67:317-324.
9. Chetelat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C et al. 2010. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain. 133:3349-3358.
10. Chetelat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN et al. 2011. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain. 134:798-807.
11. Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC. 2004. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Disord. 18:190-195
12. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA. 2005. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 26:491-510.
13. de Leon MJ, George AE, Stylopoulos LA, Smith G, Miller DC. 1989 Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet. 2:672-673.
14. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD et al. 2009. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 19:497-510.
15. Fearnley JM, Lees AJ. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 114(Pt 5):2283-2301.
16. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM. 2010. Brain atrophy in healthy aging is related to CSF levels of Abeta1-42. Cereb Cortex. 20:2069-2079.
17. Fjell AM, Walhovd KB, Reinvang I, Lundervold A, Salat D, Quinn BT, Fischl B, Dale AM. 2006. Selective increase of cortical thickness in high-performing elderly-structural indices of optimal cognitive aging. Neuroimage. 29:984-994.
18. Fjell AM, Westlye LT, Amlien I, Espeseth T, Reinvang I, Raz N, Agartz I, Salat DH, Greve DN, Fischl B et al. 2009. High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex. 19:2001-2012.
19. Genovese CR, Lazar NA, Nichols T. 2002. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 15:870-878.
20. Goldman-Rakic PS. 1987. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Mountcas-tle VB, Plum F, editors. Handbook of physiology: the nervous system, higher functions of the brain. Bethesda (MD): American Physiological Society. p. 373-417.
21. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frack-owiak RS. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 14:21-36.
22. Grady CL, Craik FI. 2000. Changes in memory processing with age. Curr Opin Neurobiol. 10:224-231.
23. Gunning-Dixon FM, Raz N. 2003. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia. 41:1929-1941.
24. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA et al. 2008. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 131:665-680.
25. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ et al. 2009. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 132:1355-1365.
26. Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, Oikonen V, Kailajarvi M, Scheinin M, Viitanen M et al. 2007. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology. 68:1603-1606.
27. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 16:834-840.
28. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A. 1993. Correction for head size in brain-imaging measurements. Psychiatry Res. 50:121-139.
29. Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. 2003. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 46:2740-2754.
30. Moffat SD, Kennedy KM, Rodrigue KM, Raz N. 2007. Extrahippocam-pal contributions to age differences in human spatial navigation. Cereb Cortex. 17:1274-1282.
31. Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. 2012. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59:1152-1160.
32. Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. 2009. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain. 132: 1310-1323.
33. Oh H, Madison C, Haight TJ, Markley C, Jagust WJ. 2012. Effects of age and beta-amyloid on cognitive changes in normal elderly people. Neurobiol Aging. 33:2746-2755.
34. Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ. 2011. beta-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 54:1887-1895.
35. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA. 2005. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 25:1528-1547.
36. Rajah MN, Kromas M, Han JE, Pruessner JC. 2010. Group differences in anterior hippocampal volume and in the retrieval of spatial and temporal context memory in healthy young versus older adults. Neuropsychologia. 48:4020-4030.
37. Rajah MN, Languay R, Grady CL. 2011. Age-related changes in right middle frontal gyrus volume correlate with altered episodic retrieval activity. J Neurosci. 31:17941-17954.
38. Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, Loken WJ, Thornton AE, Acker JD. 1997. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex. 7:268-282.
39. Raz N, Rodrigue KM, Kennedy KM, Head D, Gunning-Dixon F, Acker JD. 2003. Differential aging of the human striatum: longitudinal evidence. AJNR Am J Neuroradiol. 24:1849-1856.
40. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RS, Busa E, Morris JC, Dale AM, Fischl B. 2004. Thinning of the cerebral cortex in aging. Cereb Cortex. 14:721-730.
41. Salat DH, Kaye JA, Janowsky JS. 2002. Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. Cereb Cortex. 12:494-505.
42. Schretlen D, Pearlson GD, Anthony JC, Aylward EH, Augustine AM, Davis A, Barta P. 2000. Elucidating the contributions of processing speed, executive ability, and frontal lobe volume to normal age-related differences in fluid intelligence. J Int Neuropsychol Soc. 6:52-61.
43. Sorg C, Riedl V, Muhlau M, Calhoun VD, Eichele T, Laer L, Drzezga A, Forstl H, Kurz A, Zimmer C et al. 2007. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA. 104:18760-18765.
44. Storandt M, Mintun MA, Head D, Morris JC. 2009. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol. 66:1476-1481.
45. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. 2011. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 134: 1077-1088.
46. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ. 2004. White matter lesions impair frontal lobe function regardless of their location. Neurology. 63:246-253.